<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">JDM</journal-id><journal-title-group><journal-title>Journal of Diabetes Mellitus</journal-title></journal-title-group><issn pub-type="epub">2160-5831</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/jdm.2023.131003</article-id><article-id pub-id-type="publisher-id">JDM-122634</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Risks Factors Associated with Diabetic Retinopathy at the National University Hospital Center Hubert Koutoukou Maga in Cotonou
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Annelie</surname><given-names>Kerekou Hode</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Chakiratou</surname><given-names>Abouki</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Alihonou</surname><given-names>Hubert Dedjan</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Aurelia</surname><given-names>Doutetien Djossou</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Nestor</surname><given-names>Aïgbe</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Gloria</surname><given-names>Djohossou</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Soulé</surname><given-names>Alamou</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Lisette</surname><given-names>Odoulami</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ignace</surname><given-names>Sounouvou</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sidonie</surname><given-names>Tchabi</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>National University Hospital Center/Hubert Koutoukou MAGA (CNHU/HKM), Cotonou, Benin</addr-line></aff><aff id="aff5"><addr-line>University Hospital of Zone/Suru-Léré (CHUZ/SL), Cotonou, Benin</addr-line></aff><aff id="aff2"><addr-line>Ophthalmology Teaching Unit, Faculty of Health Sciences of the University of Abomey-Calavi, Abomey-Calavi, Benin</addr-line></aff><aff id="aff6"><addr-line>Departmental University Hospital of Ouémé Plateau (CHUD/OP), Porto-Novo, Benin</addr-line></aff><aff id="aff4"><addr-line>Army Instruction Hospital, Cotonou University Hospital Center, Cotonou, Benin</addr-line></aff><aff id="aff1"><addr-line>Endocrinology Teaching Unit, Faculty of Health Sciences of the University of Abomey-Calavi, Abomey-Calavi, Benin</addr-line></aff><pub-date pub-type="epub"><day>06</day><month>01</month><year>2023</year></pub-date><volume>13</volume><issue>01</issue><fpage>23</fpage><lpage>35</lpage><history><date date-type="received"><day>10,</day>	<month>September</month>	<year>2021</year></date><date date-type="rev-recd"><day>26,</day>	<month>January</month>	<year>2023</year>	</date><date date-type="accepted"><day>29,</day>	<month>January</month>	<year>2023</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Diabetic retinopathy (DR) is one of the microvascular complications of diabetes. The aim of this study was to analyze the risk factors associated with the occurrence of diabetic retinopathy (DR) at the National University Hospital Center-Hubert Koutoukou MAGA (CNHU-HKM). Patients and method: this was a descriptive and analytical cross-sectional study with prospective data collection. It was carried out over a three-month period from July 10 to October 10, 2019. It concerned all patients suffering from diabetes mellitus and who consulted in the Endocrinology department during the study period. Results: the frequency of diabetic retinopathy was 30.46% (53/174 patients). A female predominance was observed with a sex ratio (M/F) of 0.57. The main modifiable risk factors were represented by occupation and those that were not modifiable were represented by the presence of old nephropathy, glycated hemoglobin, age of discovery of diabetes and its length of service. Diabetic retinopathy is a serious condition that can ultimately lead to blindness. The frequency of DR remains high in our study.
 
</p></abstract><kwd-group><kwd>Associated Factors</kwd><kwd> Modifiable or Not</kwd><kwd> Diabetic Retinopathy</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Diabetic retinopathy (DR) is one of the microvascular complications of diabetes. It’s a public health problem [<xref ref-type="bibr" rid="scirp.122634-ref1">1</xref>]. International Diabetes Federation (IDF) valued about a third of people with diabetes develop diabetic retinopathy [<xref ref-type="bibr" rid="scirp.122634-ref2">2</xref>]. In Africa, data from the literature places the overall prevalence of diabetic retinopathy at 30% (15% - 52% of people with diabetes) [<xref ref-type="bibr" rid="scirp.122634-ref3">3</xref>]. It is a major cause of loss vision and is the leading cause of blindness before the age of 55 [<xref ref-type="bibr" rid="scirp.122634-ref4">4</xref>]. The cost of DR before the stage of blindness is relatively low compared to that of other complications of diabetes. However, the cost of blindness is much higher, and is among the most costly complications of diabetes [<xref ref-type="bibr" rid="scirp.122634-ref5">5</xref>]. Many studies found that diabetic retinopathy was associated to several risk factors [<xref ref-type="bibr" rid="scirp.122634-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.122634-ref7">7</xref>]. It therefore appears important to know the factors linked to the occurrence of diabetic retinopathy in order to better control them in order to reduce the prevalence of this condition.</p></sec><sec id="s2"><title>2. Patients and Method</title><p>This was a cross-sectional descriptive and analytical study with prospective data collection. It was carried out over a three-month period from July 10 to October 10, 2019. It was represented by a group of patients suffering from diabetes mellitus and who consulted in the Endocrinology department during the study period. Were included in the study, patients aged at least 18 years, suffering from diabetes mellitus (type 1 or 2), having consulted in the Endocrinology department of the CNHU-HKM, undergoing a background examination eye in the Ophthalmology department and consenting to the study. All patients with blindness and pregnant women were excluded from the study. An exhaustive recruitment of all patients meeting our study criteria was carried out. The dependent variable was represented by diabetic retinopathy. The independent variables were for non modifiable risk factors which were age, sex, type of diabetes, duration of diabetes, age of onset of diabetes, family history of diabetes and high blood pressure. Modifiable risk factors such as level of education, occupation, overweight, obesity and abdominal obesity, alcoholism, smoking, physical inactivity, nephropathy, neuropathy, treatment with insulin, oral antidiabetics (ADO) and herbal teas, diabetes imbalance (glycated hemoglobin &gt; 7%), LDL and total hypercholesterolemia, hypertriglyceridemia and the presence of a significant 24-hour microalbuminuria.</p><p>Data collection was carried out by a questionnaire and a smartphone on which the Kobo-collect software for data recording was installed. All patients received a free fundus in the ophthalmology department. Data analysis was performed with SPSS software version 25.0. Proportions were calculated for qualitative variables. Means and standard deviations were calculated for the description of quantitative variables. Bivariate analysis was performed to identify associated factors. The comparison of the proportions was made using Fisher’s tests, Yates’s Chi<sup>2</sup> and Pearson’s Chi<sup>2</sup>. The Fisher test was considered when the smallest theoretical size was less than or equal to 3, Yates’ Chi<sup>2</sup> when it is greater than 3 and less than or equal to 5 and Pearson’s Chi<sup>2</sup> when it is strictly greater than 5. The difference was statistically significant for a p-value less than 0.05. The strength of the association was assessed using the Odds Ratio (OR) and its 95% confidence interval (95% CI OR). The tables and figures were performed using Microsoft Office Word and Excel version 2016 software. The patients’ oral, free and informed consent was obtained. All data collected anonymously during the investigation was used only for this study and was kept strictly confidential. The difficulty encountered was the non-availability of patients to honor ophthalmology appointments.</p></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. Frequency of Diabetic Retinopathy</title><p>A total of 174 subjects were included, of which 53 had diabetic retinopathy, then a frequency of 30.46%.</p></sec><sec id="s3_2"><title>3.2. Risks Factors Associated with Diabetic Retinopathy</title><sec id="s3_2_1"><title>3.2.1. Modifiable Risk Factors</title><p>Sociodemographic Characteristics</p><p><xref ref-type="table" rid="table1">Table 1</xref> shows the distribution of diabetic retinopathy according to marital status, level of education, professional status and religion.</p><p>Occupation was the only modifiable socio-demographic factor associated with the occurrence of diabetic retinopathy (p = 0.035). Retired people (odds ratio at 13.51 with a confidence interval between 1.70 and 107.25) as well as employees</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Diabetic retinopathy (DR) according to marital status, level of education, professional status and religion</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  ></th><th align="center" valign="middle"  rowspan="2"  >Total</th><th align="center" valign="middle"  colspan="2"  >DR</th><th align="center" valign="middle"  rowspan="2"  >OR</th><th align="center" valign="middle"  rowspan="2"  >IC 95%</th><th align="center" valign="middle"  colspan="2"   rowspan="2"  >p-value</th></tr></thead><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >%</td></tr><tr><td align="center" valign="middle"  colspan="8"  >Marital status</td></tr><tr><td align="center" valign="middle" >Married</td><td align="center" valign="middle" >137</td><td align="center" valign="middle" >44</td><td align="center" valign="middle" >32.12</td><td align="center" valign="middle" >1.47</td><td align="center" valign="middle" >[0.64 - 3.38]</td><td align="center" valign="middle" >p = 0.360</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Unmarried</td><td align="center" valign="middle" >37</td><td align="center" valign="middle" >09</td><td align="center" valign="middle" >24.32</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle"  colspan="2"  ></td></tr><tr><td align="center" valign="middle"  colspan="8"  >Educational level</td></tr><tr><td align="center" valign="middle" >Not in school/Primary</td><td align="center" valign="middle" >42</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >35.71</td><td align="center" valign="middle" >1.37</td><td align="center" valign="middle" >[0.65 - 2.86]</td><td align="center" valign="middle"  colspan="2"  >p = 0.238</td></tr><tr><td align="center" valign="middle" >Secondary/ university</td><td align="center" valign="middle" >132</td><td align="center" valign="middle" >38</td><td align="center" valign="middle" >28.79</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle"  colspan="2"  ></td></tr><tr><td align="center" valign="middle"  colspan="8"  >Professional situation</td></tr><tr><td align="center" valign="middle" >Retired</td><td align="center" valign="middle" >62</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >40.32</td><td align="center" valign="middle" >2.02</td><td align="center" valign="middle" >[1.04 - 3.93]</td><td align="center" valign="middle"  colspan="2"  >p = 0.035*</td></tr><tr><td align="center" valign="middle" >Working</td><td align="center" valign="middle" >112</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >25.00</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle"  colspan="2"  ></td></tr><tr><td align="center" valign="middle"  colspan="8"  >Religion</td></tr><tr><td align="center" valign="middle" >Christian</td><td align="center" valign="middle" >149</td><td align="center" valign="middle" >45</td><td align="center" valign="middle" >30.20</td><td align="center" valign="middle" >0.91</td><td align="center" valign="middle" >[0.37 - 2.28]</td><td align="center" valign="middle"  colspan="2"  >p = 0.856</td></tr><tr><td align="center" valign="middle" >others</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >08</td><td align="center" valign="middle" >32.00</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle"  colspan="2"  ></td></tr></tbody></table></table-wrap><p>* = significative p.</p><p>(odds ratio at 11.51 with a confidence interval between 1.42 and 92.74) were the most affected by diabetic retinopathy.</p></sec><sec id="s3_2_2"><title>3.2.2. Behavioral Factors</title><p><xref ref-type="table" rid="table2">Table 2</xref> illustrates the distribution of the occurrence of diabetic retinopathy (DR) according to behavioral factors.</p><p>There was no statistically significant association between behavioral factors and the occurrence of DR.</p></sec></sec><sec id="s3_3"><title>3.3. History of Peripheral Neuropathy and Nephropathy</title><p><xref ref-type="table" rid="table3">Table 3</xref> shows the distribution of the frequency of diabetic retinopathy (DR) according to the history of peripheral neuropathy and nephropathy.</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Occurrence of diabetic retinopathy according to behavioral factors</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  ></th><th align="center" valign="middle"  rowspan="2"  >Total</th><th align="center" valign="middle"  colspan="2"  >RD</th><th align="center" valign="middle"  rowspan="2"  >OR</th><th align="center" valign="middle"  rowspan="2"  >IC 95% OR</th><th align="center" valign="middle"  rowspan="2"  >p-value</th></tr></thead><tr><td align="center" valign="middle" >yes</td><td align="center" valign="middle" >%</td></tr><tr><td align="center" valign="middle"  colspan="7"  >Harmful alcohol consumption (alcohol consumption over 20 g/day for women and 30 g/day for men)</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >01</td><td align="center" valign="middle" >00</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle"  rowspan="2"  >-</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >173</td><td align="center" valign="middle" >53</td><td align="center" valign="middle" >30.64</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle"  colspan="7"  >Risky alcohol consumption (alcohol consumption over 60 g/day)</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >04</td><td align="center" valign="middle" >25.00</td><td align="center" valign="middle" >0.74</td><td align="center" valign="middle" >[0.22 - 2.41]</td><td align="center" valign="middle"  rowspan="2"  >p = 0.831</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >158</td><td align="center" valign="middle" >49</td><td align="center" valign="middle" >31.01</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="7"  >Smoking</td></tr><tr><td align="center" valign="middle" >yes</td><td align="center" valign="middle" >01</td><td align="center" valign="middle" >00</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >173</td><td align="center" valign="middle" >53</td><td align="center" valign="middle" >30.64</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="7"  >Physical activity</td></tr><tr><td align="center" valign="middle" >Insufficient</td><td align="center" valign="middle" >157</td><td align="center" valign="middle" >49</td><td align="center" valign="middle" >31.21</td><td align="center" valign="middle" >1.47</td><td align="center" valign="middle" >[0.45 - 4.75]</td><td align="center" valign="middle" >p = 0.513</td></tr><tr><td align="center" valign="middle" >Sufficient</td><td align="center" valign="middle" >17</td><td align="center" valign="middle" >04</td><td align="center" valign="middle" >23.53</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Frequency of DR according to the history of peripheral neuropathy and nephropathy</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  ></th><th align="center" valign="middle"  rowspan="2"  >Total</th><th align="center" valign="middle"  colspan="2"  >DR</th><th align="center" valign="middle"  rowspan="2"  ></th><th align="center" valign="middle"  rowspan="2"  >IC 95% OR</th><th align="center" valign="middle"  rowspan="2"  >p-value</th></tr></thead><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >%</td></tr><tr><td align="center" valign="middle"  colspan="7"  >Peripheral neuropathy</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >74</td><td align="center" valign="middle" >26</td><td align="center" valign="middle" >35.14</td><td align="center" valign="middle" >1.46</td><td align="center" valign="middle" >[0.76 - 2.80]</td><td align="center" valign="middle"  rowspan="2"  >p = 0.249</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >27</td><td align="center" valign="middle" >27.00</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="7"  >Nephropathy (N = 61)</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >34</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >41.18</td><td align="center" valign="middle" >4.02</td><td align="center" valign="middle" >[1.13 - 14.22]</td><td align="center" valign="middle"  rowspan="2"  >p = 0.024</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >27</td><td align="center" valign="middle" >04</td><td align="center" valign="middle" >14.81</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>There was a statistically significant association between DR and the existence of nephropathy (p = 0.024). Patients with nephropathy were more likely to have DR than others (odds ratio 4.02 with a confidence interval of [1.13 - 14.22]).</p></sec><sec id="s3_4"><title>3.4. Antidiabetic Treatment</title><p><xref ref-type="table" rid="table4">Table 4</xref> shows the distribution of the occurrence of DR according to the antidiabetic treatment.</p><p>There was no statistically significant association between diabetes treatment and DR.</p></sec><sec id="s3_5"><title>3.5. Anthropometric Factors</title><p><xref ref-type="table" rid="table5">Table 5</xref> summarizes the distribution of the occurrence of DR according to anthropometric factors.</p><p>There was no statistically significant association between these factors and the existence of diabetic retinopathy.</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Distribution of DR according to antidiabetic treatment</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  ></th><th align="center" valign="middle"  rowspan="2"  >Total</th><th align="center" valign="middle"  colspan="2"  >DR</th><th align="center" valign="middle"  rowspan="2"  >OR</th><th align="center" valign="middle"  rowspan="2"  >IC 95% OR</th><th align="center" valign="middle"  rowspan="2"  >p-value</th></tr></thead><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >%</td></tr><tr><td align="center" valign="middle" >HDM</td><td align="center" valign="middle" >09</td><td align="center" valign="middle" >02</td><td align="center" valign="middle" >22.22</td><td align="center" valign="middle" >0.67</td><td align="center" valign="middle" >[0.13 - 3.40]</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >HDM + Insuline</td><td align="center" valign="middle" >22</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >45.45</td><td align="center" valign="middle" >1.97</td><td align="center" valign="middle" >[0.79 - 4.95]</td><td align="center" valign="middle" >p = 0.249</td></tr><tr><td align="center" valign="middle" >MHD + OAD + Insuline</td><td align="center" valign="middle" >06</td><td align="center" valign="middle" >01</td><td align="center" valign="middle" >16.67</td><td align="center" valign="middle" >0.47</td><td align="center" valign="middle" >[0.05 - 4.19]</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Tisane</td><td align="center" valign="middle" >02</td><td align="center" valign="middle" >00</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >HDM + OAD</td><td align="center" valign="middle" >135</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >29.63</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>HDM = Hygiene and dietetic measures; OAD = Oral antidiabetics.</p><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Distribution of DR according to anthropometric factors</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  ></th><th align="center" valign="middle"  rowspan="2"  >Total</th><th align="center" valign="middle"  colspan="2"  >RD</th><th align="center" valign="middle"  rowspan="2"  >OR</th><th align="center" valign="middle"  rowspan="2"  >IC 95% OR</th><th align="center" valign="middle"  rowspan="2"  >p-value</th></tr></thead><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >%</td></tr><tr><td align="center" valign="middle"  colspan="7"  >Abdominal obesity according to NCEP*</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >104</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >26.92</td><td align="center" valign="middle" >0.66</td><td align="center" valign="middle" >[0.34 - 1.27]</td><td align="center" valign="middle" >p = 0.216</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >70</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >35.71</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="7"  >Abdominal obesity according to IDF**</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >143</td><td align="center" valign="middle" >44</td><td align="center" valign="middle" >30.77</td><td align="center" valign="middle" >1.08</td><td align="center" valign="middle" >[0.46 - 2.54]</td><td align="center" valign="middle" >p = 0.848</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >31</td><td align="center" valign="middle" >09</td><td align="center" valign="middle" >29.03</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="7"  >Body Mass Index (BMI)</td></tr><tr><td align="center" valign="middle" >overweight/Obesity</td><td align="center" valign="middle" >123</td><td align="center" valign="middle" >37</td><td align="center" valign="middle" >30.08</td><td align="center" valign="middle" >0.94</td><td align="center" valign="middle" >[0.46 - 1.90]</td><td align="center" valign="middle" >p = 0.866</td></tr><tr><td align="center" valign="middle" >Thinness/Normal</td><td align="center" valign="middle" >51</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >31.37</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>NCEP* = National Cholesterol Prevention Program; IDF** = International diabetes federation.</p></sec><sec id="s3_6"><title>3.6. Biological Parameters</title><p><xref ref-type="table" rid="table6">Table 6</xref> shows the distribution of the occurrence of DR according to the biological parameters.</p><p>Glycemic imbalance was strongly associated with the development of DR (p &lt; 0.001). People who had glycated hemoglobin ≥ 7% were the most affected by this condition (odds ratio at 3.36 with a confidence interval of [1.60 - 7.04]). There was an association between 24-hour microalbuminuria and the existence of DR. Subjects with significant 24-hour microalbuminuria (&gt;30 mg) were more likely to have DR (p = 0.066).</p></sec><sec id="s3_7"><title>3.7. Non-Modifiable Risk Factors</title><p>Sociodemographic characteristics</p><p><xref ref-type="table" rid="table7">Table 7</xref> shows the distribution of the frequency of DR by age, sex and ethnicity.</p><p>There was no statistically significant association between age, gender, ethnicity and DR.</p></sec><sec id="s3_8"><title>3.8. History of High Blood Pressure and Familial Diabetes</title><p><xref ref-type="table" rid="table8">Table 8</xref> shows the distribution of the frequency of DR according to the history of high blood pressure and familial diabetes</p><p>There was a significant association between diabetic retinopathy and high blood pressure (p = 0.002). DR was much more common in people with hypertension (odds ratio of 3.45 with a confidence interval of [1.49 - 7.96]).</p><table-wrap id="table6" ><label><xref ref-type="table" rid="table6">Table 6</xref></label><caption><title> Distribution of DR according to the biological parameters</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  ></th><th align="center" valign="middle"  rowspan="2"  >Total</th><th align="center" valign="middle"  colspan="2"  >RD</th><th align="center" valign="middle"  rowspan="2"  >OR</th><th align="center" valign="middle"  rowspan="2"  >IC 95% OR</th><th align="center" valign="middle"  rowspan="2"  >p-value</th></tr></thead><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >%</td></tr><tr><td align="center" valign="middle"  colspan="7"  >Total cholesterol (N = 97)</td></tr><tr><td align="center" valign="middle" >&gt;2.25 g/l</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >00</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle"  rowspan="2"  >-</td></tr><tr><td align="center" valign="middle" >≤2.25 g/l</td><td align="center" valign="middle" >84</td><td align="center" valign="middle" >27</td><td align="center" valign="middle" >32.14</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle"  colspan="7"  >LDL cholesterol (N = 89)</td></tr><tr><td align="center" valign="middle" >&gt;1.5 g/l</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >01</td><td align="center" valign="middle" >07.14</td><td align="center" valign="middle" >0.16</td><td align="center" valign="middle" >[0.02 - 1.32]</td><td align="center" valign="middle"  rowspan="2"  >p = 0.115</td></tr><tr><td align="center" valign="middle" >≤1.5 g/l</td><td align="center" valign="middle" >75</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >32.00</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="7"  >Triglyceridemia (N = 96)</td></tr><tr><td align="center" valign="middle" >&gt;1.5 g/l</td><td align="center" valign="middle" >08</td><td align="center" valign="middle" >01</td><td align="center" valign="middle" >12.50</td><td align="center" valign="middle" >0.36</td><td align="center" valign="middle" >[0.04 - 3.07]</td><td align="center" valign="middle"  rowspan="2"  >p = 0.442</td></tr><tr><td align="center" valign="middle" >≤1.5 g/l</td><td align="center" valign="middle" >88</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >28.41</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="7"  >Glycated hemoglobin (N = 159)</td></tr><tr><td align="center" valign="middle" >&gt;7%</td><td align="center" valign="middle" >83</td><td align="center" valign="middle" >34</td><td align="center" valign="middle" >40.96</td><td align="center" valign="middle" >3.36</td><td align="center" valign="middle" ></td><td align="center" valign="middle"  rowspan="2"  >p &lt; 0.001*</td></tr><tr><td align="center" valign="middle" >≤7%</td><td align="center" valign="middle" >76</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >17.11</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="7"  >24-hour micro albuminuria (N = 61)</td></tr><tr><td align="center" valign="middle" >&gt;30 mg</td><td align="center" valign="middle" >33</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >39.39</td><td align="center" valign="middle" >2.99</td><td align="center" valign="middle" >[0.90 - 9.85]</td><td align="center" valign="middle"  rowspan="2"  >p = 0.066</td></tr><tr><td align="center" valign="middle" >≤30 mg</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >05</td><td align="center" valign="middle" >17.86</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>* = significative p.</p><table-wrap id="table7" ><label><xref ref-type="table" rid="table7">Table 7</xref></label><caption><title> Frequency of DR by age, sex and ethnicity</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  ></th><th align="center" valign="middle"  rowspan="2"  >Total</th><th align="center" valign="middle"  colspan="2"  >DR</th><th align="center" valign="middle"  rowspan="2"  >OR</th><th align="center" valign="middle"  rowspan="2"  >IC 95% OR</th><th align="center" valign="middle"  rowspan="2"  >p-value</th></tr></thead><tr><td align="center" valign="middle" >yes</td><td align="center" valign="middle" >%</td></tr><tr><td align="center" valign="middle"  colspan="7"  >Age (years)</td></tr><tr><td align="center" valign="middle" >&gt;57</td><td align="center" valign="middle" >87</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >32.18</td><td align="center" valign="middle" >1.17</td><td align="center" valign="middle" >[0.61 - 2.24]</td><td align="center" valign="middle"  rowspan="2"  >p = 0.621</td></tr><tr><td align="center" valign="middle" >≤57</td><td align="center" valign="middle" >87</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >28.74</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="7"  >Sex</td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >75</td><td align="center" valign="middle" >23</td><td align="center" valign="middle" >30.67</td><td align="center" valign="middle" >1.01</td><td align="center" valign="middle" >[0.53 - 1.95]</td><td align="center" valign="middle"  rowspan="2"  >p = 0.958</td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >99</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >30.30</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="7"  >Ethnicity</td></tr><tr><td align="center" valign="middle" >local language</td><td align="center" valign="middle" >110</td><td align="center" valign="middle" >32</td><td align="center" valign="middle" >29.09</td><td align="center" valign="middle" >0.84</td><td align="center" valign="middle" >[0.43 - 1.63]</td><td align="center" valign="middle"  rowspan="2"  >p = 0.607</td></tr><tr><td align="center" valign="middle" >Others</td><td align="center" valign="middle" >64</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >32.81</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><table-wrap id="table8" ><label><xref ref-type="table" rid="table8">Table 8</xref></label><caption><title> Frequency of DR according to the history of high blood pressure (HBP) and familial diabetes</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  ></th><th align="center" valign="middle"  rowspan="2"  >Total</th><th align="center" valign="middle"  colspan="2"  >DR</th><th align="center" valign="middle"  rowspan="2"  >OR</th><th align="center" valign="middle"  rowspan="2"  >IC 95% OR</th><th align="center" valign="middle"  colspan="2"   rowspan="2"  >p-value</th></tr></thead><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >%</td></tr><tr><td align="center" valign="middle"  colspan="8"  >HBP</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >120</td><td align="center" valign="middle" >45</td><td align="center" valign="middle" >37.50</td><td align="center" valign="middle" >3.45</td><td align="center" valign="middle"  colspan="2"  >[1.49 - 7.96]</td><td align="center" valign="middle"  rowspan="2"  >p = 0.002*</td></tr><tr><td align="center" valign="middle" >N</td><td align="center" valign="middle" >54</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >14.81</td><td align="center" valign="middle" >1</td><td align="center" valign="middle"  colspan="2"  ></td></tr><tr><td align="center" valign="middle"  colspan="8"  >Duration of HBP (years) (N = 120)</td></tr><tr><td align="center" valign="middle" >&gt;7</td><td align="center" valign="middle" >58</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >32.76</td><td align="center" valign="middle" >0.67</td><td align="center" valign="middle"  colspan="2"  >[0.32 - 1.42]</td><td align="center" valign="middle"  rowspan="2"  >p = 0.299</td></tr><tr><td align="center" valign="middle" >≤7</td><td align="center" valign="middle" >62</td><td align="center" valign="middle" >26</td><td align="center" valign="middle" >41.94</td><td align="center" valign="middle" >1</td><td align="center" valign="middle"  colspan="2"  ></td></tr><tr><td align="center" valign="middle"  colspan="8"  >Familial diabetes</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >119</td><td align="center" valign="middle" >37</td><td align="center" valign="middle" >31.09</td><td align="center" valign="middle" >1.10</td><td align="center" valign="middle"  colspan="2"  >[0.54 - 2.21]</td><td align="center" valign="middle"  rowspan="2"  >p = 0.789</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >55</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >29.09</td><td align="center" valign="middle" >1</td><td align="center" valign="middle"  colspan="2"  ></td></tr><tr><td align="center" valign="middle"  colspan="8"  >Familial diabetes relationship (N = 119)</td></tr><tr><td align="center" valign="middle" >first-degree relative</td><td align="center" valign="middle" >98</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >28.57</td><td align="center" valign="middle" >0.53</td><td align="center" valign="middle"  colspan="2"  >[0.20 - 1.40]</td><td align="center" valign="middle"  rowspan="2"  >p = 0.199</td></tr><tr><td align="center" valign="middle" >second degree relative</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >09</td><td align="center" valign="middle" >42.86</td><td align="center" valign="middle" >1</td><td align="center" valign="middle"  colspan="2"  ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>* = significative p.</p></sec><sec id="s3_9"><title>3.9. Characteristics of Diabetes</title><p><xref ref-type="table" rid="table9">Table 9</xref> shows the distribution of the occurrence of DR according to the age of discovery of diabetes, the type of diabetes and its duration.</p><p>Duration of diabetes was significantly associated with the occurrence of DR (p &lt; 0.001). Subjects diagnosed with diabetes for more than 5 years were more affected by DR than others (odds ratio 5.02 with a confidence interval of [2.39 - 10.50]). There was also a statistically significant association between age of discovery of diabetes and DR (p = 0.029). Patients whose age was 48 years or less at the time of diagnosis of diabetes were the most affected by this condition (odds ratio 2.07 with a confidence interval of [1.06 - 4.04]).</p><table-wrap id="table9" ><label><xref ref-type="table" rid="table9">Table 9</xref></label><caption><title> Distribution of DR according to age of onset of diabetes, type of diabetes and its duration</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  ></th><th align="center" valign="middle"  rowspan="2"  >Total</th><th align="center" valign="middle"  colspan="2"  >DR</th><th align="center" valign="middle"  rowspan="2"  >OR</th><th align="center" valign="middle"  rowspan="2"  >IC 95% OR</th><th align="center" valign="middle"  rowspan="2"  >p-value</th></tr></thead><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >%</td></tr><tr><td align="center" valign="middle"  colspan="7"  >Duration of diabetes (years)</td></tr><tr><td align="center" valign="middle" >&gt;5</td><td align="center" valign="middle" >90</td><td align="center" valign="middle" >41</td><td align="center" valign="middle" >45.56</td><td align="center" valign="middle" >5.02</td><td align="center" valign="middle" >[2.39 - 10.50]</td><td align="center" valign="middle"  rowspan="2"  >p &lt; 0.001*</td></tr><tr><td align="center" valign="middle" >≤5</td><td align="center" valign="middle" >84</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >14.29</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="7"  >Age onset of diabetes (en ann&#233;es)</td></tr><tr><td align="center" valign="middle" >≤48</td><td align="center" valign="middle" >90</td><td align="center" valign="middle" >34</td><td align="center" valign="middle" >37.78</td><td align="center" valign="middle" >2.07</td><td align="center" valign="middle" >[1.06 - 4.04]</td><td align="center" valign="middle"  rowspan="2"  >p = 0.029*</td></tr><tr><td align="center" valign="middle" >&gt;48</td><td align="center" valign="middle" >84</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >22.62</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="7"  >Type of diabetes</td></tr><tr><td align="center" valign="middle" >Type 2</td><td align="center" valign="middle" >167</td><td align="center" valign="middle" >52</td><td align="center" valign="middle" >31.14</td><td align="center" valign="middle" >2.71</td><td align="center" valign="middle" >[0.31 - 23.11]</td><td align="center" valign="middle"  rowspan="2"  >p = 0.676</td></tr><tr><td align="center" valign="middle" >Type 1</td><td align="center" valign="middle" >07</td><td align="center" valign="middle" >01</td><td align="center" valign="middle" >14.29</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>*=significative p.</p></sec></sec><sec id="s4"><title>4. Discussion</title><sec id="s4_1"><title>4.1. Frequency of Diabetic Retinopathy</title><p>The frequency of DR was 30.46% in our study. It is close to the 33% of Nwosu et al. [<xref ref-type="bibr" rid="scirp.122634-ref6">6</xref>] in Nigeria in 2000 and 36.6% of Tchabi et al. [<xref ref-type="bibr" rid="scirp.122634-ref7">7</xref>] in Benin in 2012. However, Abouki et al. [<xref ref-type="bibr" rid="scirp.122634-ref8">8</xref>] in Benin in 2016, Kouassi et al. [<xref ref-type="bibr" rid="scirp.122634-ref9">9</xref>] in C&#244;te-d’Ivoire in 2018 and Diallo et al. [<xref ref-type="bibr" rid="scirp.122634-ref10">10</xref>] in Burkina-Faso in 2014 found higher frequencies of 43.33%, 45% and 47.1% respectively. Rajoana et al. [<xref ref-type="bibr" rid="scirp.122634-ref11">11</xref>] in 2016 in Madagascar reported a higher frequency of 65.8%. These results illustrate the importance of DR within our populations and call for our actions to be focused on preventive measures. In contrast, Magulike et al. [<xref ref-type="bibr" rid="scirp.122634-ref12">12</xref>] in 2003 in Nigeria, Omolase et al. [<xref ref-type="bibr" rid="scirp.122634-ref13">13</xref>] in 2010 in Nigeria, Assavedo et al. [<xref ref-type="bibr" rid="scirp.122634-ref14">14</xref>] in 2016 in Benin, Djagadou et al. [<xref ref-type="bibr" rid="scirp.122634-ref15">15</xref>] in 2017 in Togo and Maammar et al. [<xref ref-type="bibr" rid="scirp.122634-ref16">16</xref>] in 2013 in Algeria found lower frequencies respectively 12.75%, 15%, 17.46%, 22.73% and 25.37%. The disparity in these frequencies may be related to the difference in size and to the sampling techniques that differ from one study to another.</p></sec><sec id="s4_2"><title>4.2. Risk Factors for Diabetic Retinopathy</title>Modifiable Risk Factors<p>Level of Education</p><p>In our study, the frequency of DR was slightly higher in people with a low level of education (out of school/primary) than in others (35.71% versus 28.79%). This result agrees with that of Abouki et al. [<xref ref-type="bibr" rid="scirp.122634-ref8">8</xref>] in Porto-Novo in Benin in 2016 who reported that this condition was predominant among illiterates (55.36%) and subjects with a primary education level (45.45%). In contrast, Cui et al. [<xref ref-type="bibr" rid="scirp.122634-ref17">17</xref>] in China in 2019 noted that DR was predominantly present in people with a high level of education (secondary/higher), i.e. 51.9%. In all cases, the level of education is not a risk factor for DR (odds ratio at 1.37 with a 95% confidence interval between 0.65 and 2.86; p = 0.395).</p></sec><sec id="s4_3"><title>4.3. Professional Situation</title><p>Some authors have found a higher proportion of DR among the unemployed. This is the case with Abouki et al. [<xref ref-type="bibr" rid="scirp.122634-ref8">8</xref>] in Porto-Novo in Benin (57.14%) in 2016 and from Ben et al. [<xref ref-type="bibr" rid="scirp.122634-ref18">18</xref>] in Tunisia (40%) in 2016. This result could be explained by the social situation of unemployed people who are unable to provide for correct and efficient management of their condition. It emerges from this study that occupation constitutes a risk factor for DR (for retirees, odds ratio at 2.02 with a 95% confidence interval between 1.04 and 3.93; p = 0.035).</p></sec><sec id="s4_4"><title>4.4. Antidiabetic Treatment</title><p>The frequency of DR was higher in subjects taking insulin (45.45%). The same observation was made by Pirie et al. [<xref ref-type="bibr" rid="scirp.122634-ref19">19</xref>] in 2014 in South Africa. In 2012 in Rwanda, Giraneza et al. [<xref ref-type="bibr" rid="scirp.122634-ref20">20</xref>] meanwhile, reported a lower proportion than ours, 37.17%. These differences could be explained by the sample sizes of these studies. Treatment regimen is not a risk factor for DR (odds ratio at 1.97 with a 95% confidence interval between 0.79 and 4.95; p = 0.395).</p></sec><sec id="s4_5"><title>4.5. Diabetic Nephropathy</title><p>Diabetic retinopathy was more represented in people with diabetic nephropathy at 41.18% (vs. 14.81%). This result is similar to that of Assavedo et al. [<xref ref-type="bibr" rid="scirp.122634-ref14">14</xref>] in Parakou in Benin in 2014 who reported that 21.9% (compared to 5.8%) of subjects with diabetic nephropathy developed parallel DR, but also that of He et al. [<xref ref-type="bibr" rid="scirp.122634-ref21">21</xref>] in China (43.06% against 25.33%) in 2012. However, Rasoulinejad et al. [<xref ref-type="bibr" rid="scirp.122634-ref22">22</xref>] in Iran in 2015 objected that DR was present in almost equal proportion in patients already with the stage of diabetic nephropathy (67.74%) and in those who are not (64.53%). However, diabetic nephropathy is a risk factor for DR (odds ratio 4.02 with a 95% confidence interval between 1.13 and 14.22; p = 0.024).</p></sec><sec id="s4_6"><title>4.6. Glycemic Imbalance</title><p>DR was present in 40.96% of patients with poor glycemic control. This same observation was made by Djrolo et al. [<xref ref-type="bibr" rid="scirp.122634-ref23">23</xref>] in Benin (94.6%) in 2014, Lopez et al. [<xref ref-type="bibr" rid="scirp.122634-ref24">24</xref>] in Spain (16.82%) in 2017. A UKPDS study in type 2 diabetics demonstrated the role of glycemic imbalance in the incidence and progression of DR [<xref ref-type="bibr" rid="scirp.122634-ref25">25</xref>]. Diabetes imbalance is indeed a risk factor for DR (odds ratio at 3.36 with a 95% confidence interval between 1.60 and 7.04; p &lt; 0.001).</p></sec><sec id="s4_7"><title>4.7. Microalbuminuria</title><p>In our study, DR was predominantly present at 39.39% in diabetics who had significant microalbuminuria (&gt;30 mg/24h). This result is comparable to those of Abouki et al. [<xref ref-type="bibr" rid="scirp.122634-ref8">8</xref>] in Porto-Novo in Benin (66.67%) in 2016 and Berkia et al. [<xref ref-type="bibr" rid="scirp.122634-ref25">25</xref>] in Morocco (53.1%) in 2014 but in higher proportions. However, microalbuminuria is not a risk factor for DR (odds ratio at 2.99 with a 95% confidence interval between 0.90 and 9.85; p = 0.066).</p></sec><sec id="s4_8"><title>4.8. Type of Diabetes</title><p>DR was more common in type 2 diabetes in our study at 31.14% versus 14.29%. In fact, it usually occurs after 7 years of diabetes in type 1 diabetics, and 20% of type 2 diabetics had it when their diabetes was discovered [<xref ref-type="bibr" rid="scirp.122634-ref26">26</xref>]. However, in 2015 in Rabat, Morocco, Andaloussi et al. [<xref ref-type="bibr" rid="scirp.122634-ref27">27</xref>] obtained similar results for the two types of diabetes (40.5% for type 1 and 38.9% for type 2) with regard to the occurrence of this condition. However, the type of diabetes is not a risk factor for DR (odds ratio 2.71 with a 95% confidence interval between 0.31 and 23.11; p = 0.676).</p></sec><sec id="s4_9"><title>4.9. Duration of Diabetes</title><p>Many studies have shown an increase in the frequency of DR with the age of diabetes. Mallika et al. [<xref ref-type="bibr" rid="scirp.122634-ref28">28</xref>] noted in Malaysia in 2011 a faster development of DR when the age of diabetes is greater than 15 years. Cui et al. [<xref ref-type="bibr" rid="scirp.122634-ref17">17</xref>] in China in 2019 found as proportions of DR 15.02%, 43.59% and 66.67% respectively in subjects diagnosed for less than 5 years, 5 to 10 years and more than 10 years. The duration of diabetes is therefore a risk factor for DR (odds ratio 5.02 with a 95% confidence interval between 2.39 and 10.50; p &lt; 0.001).</p></sec><sec id="s4_10"><title>4.10. Age Onset of Diabetes</title><p>People diagnosed with diabetes at younger ages (≤48 years) had more DR (37.78%). This result was similar on that obtained in 2016 by Zou et al. [<xref ref-type="bibr" rid="scirp.122634-ref15">15</xref>] in China who found that young age at discovery of diabetes (&lt;45 years) is a factor favoring the development of DR. In contrast, Ahmed et al. [<xref ref-type="bibr" rid="scirp.122634-ref29">29</xref>] in 2016, Saudi Arabia found that DR was more common when the age of discovery of diabetes was over 45 years (70.6% vs. 58%). This difference could be explained by the fact that this study only took into account type 2 diabetics. Thus, the age onset of diabetes is a risk factor for DR (odds ratio at 2.07 with a 95% confidence interval between 1.06 and 4.04; p = 0.029).</p></sec><sec id="s4_11"><title>4.11. High Blood Pressure</title><p>Based on the literature, there is a strong link between DR and high blood pressure. According to a study by the UKPDS (United Kingdom Prospective Diabetes Study), strict balancing of blood pressure in type 2 diabetics was highly beneficial because it would reduce the incidence of microvascular complications by 37% and reduce the increase in DR by 34% [<xref ref-type="bibr" rid="scirp.122634-ref9">9</xref>]. In Senegal in 2008, De M&#233;deiros-Quenum et al. [<xref ref-type="bibr" rid="scirp.122634-ref30">30</xref>] noted that 77.77% of hypertensive patients presented with DR. Conversely, in Porto-Novo in Benin in 2016, Abouki et al. [<xref ref-type="bibr" rid="scirp.122634-ref8">8</xref>] objected that 50% of non-hypertensive diabetics developed DR while 40.91% of hypertensive patients were affected. In our study, DR was more found in hypertensive than in non-hypertensive (37.50% versus 14.81%). High blood pressure is also a risk factor for DR (odds ratio at 3.45 with a 95% confidence interval between 1.49 and 7.96; p = 0.002).</p></sec></sec><sec id="s5"><title>5. Conclusion</title><p>Diabetic retinopathy is a serious condition that can ultimately lead to blindness. The frequency of DR remains high and requires consideration of risk factors in the monitoring of diabetics in order to prevent this preventable cause of blindness. The prevention and promotion of ocular eye health requires large-scale awareness of these risk factors identified in our context.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Kerekou Hode, A., Abouki, C., Dedjan, A.H., Djossou, A.D., A&#239;gbe, N., Djohossou, G., Alamou, S., Odoulami, L., Sounouvou, I. and Tchabi, S. (2023) Risks Factors Associated with Diabetic Retinopathy at the National University Hospital Center Hubert Koutoukou Maga in Cotonou. Journal of Diabetes Mellitus, 13, 23-35. https://doi.org/10.4236/jdm.2023.131003</p></sec></body><back><ref-list><title>References</title><ref id="scirp.122634-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Raverot, G. (2005) Diabète sucré de types 1 et 2 de l’enfant et de l’adulte. Institut La Conférence Hippocrate, Suresnes.</mixed-citation></ref><ref id="scirp.122634-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Ogurtsova, K., da Rocha Fernandes, J.D., Huang, Y., Linnenkamp, U., Guariguata, L., Cho, N.H., et al. (2017) IDF Diabetes Atlas: Global Estimates for the Prevalence of Diabetes for 2015 and 2040. Diabetes Research and Clinical Practice, 128, 40-50. https://doi.org/10.1016/j.diabres.2017.03.024</mixed-citation></ref><ref id="scirp.122634-ref3"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sidibe</surname><given-names> E. </given-names></name>,<etal>et al</etal>. (<year>2000</year>)<article-title>Rétinopathie diabétique à Dakar et revue de la littérature africaine</article-title><source> Diabetes &amp; Metabolism Journal</source><volume> 26</volume>,<fpage> 322</fpage>-<lpage>324</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.122634-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Ridouane, S., Ouhdouch, F. and Diouri, A. (2009) P20 Profil épidémiologique, clinique, thérapeutique et évolutif de la rétinopathie diabétique à Marrakech. Diabetes &amp; Metabolism Journal, 35, A33. https://doi.org/10.1016/S1262-3636(09)71818-X</mixed-citation></ref><ref id="scirp.122634-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Haute Autorité de Santé (2010) Dépistage de la rétinopathie diabétique par lecture différée de photographies du fond d’&amp;#339;il. HAS, Saint-Denis.</mixed-citation></ref><ref id="scirp.122634-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Nwosu, S.N.N. (2000) Diabetic Retinopathy in Nnewi, Nigeria. Nigerian Journal of Ophthalmology, 8, 7-10. https://doi.org/10.4314/njo.v8i1.11922</mixed-citation></ref><ref id="scirp.122634-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Tchabi, S., Assavedo, R., Affo, Y., Boni, S. and Doutetien, C. (2012) Biochemistry’s Risks Factors on the Appearance of Diabetic Retinopathy in the Ophthalmology Department Hospital Center of Borgou, Benin. Revue de Médecine et de Pharmacie, 2, 137-142.</mixed-citation></ref><ref id="scirp.122634-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Abouki, C., Alamou, S., Wanvoegbe, A., Gbegnon, G., Amoussou-Guenou, D., Sounouvou, I., et al. (2016) Aspects épidémiologiques de la rétinopathie diabétique au CHUD/OP de Porto-novo. Cahiers du CBRST, No. 10, 80-88.</mixed-citation></ref><ref id="scirp.122634-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Kouassi, F.X., Koman, C.E., Kra, A.N.S., Soumahoro, M., Sowagnon, T.Y.C. and N’dohi, R. (2018) Epidemiological Features of Diabetic Retinopathy in Abidjan (C&amp;#244;te d’Ivoire): A Study about 448 Patients. The Open Ophthalmology Journal, 8, 140-149. https://doi.org/10.4236/ojoph.2018.83018</mixed-citation></ref><ref id="scirp.122634-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Diallo, J., Dolo, M., Sanou, J., Yoda, A., Ahnoux-Zabsonré, A. and Méda, N. (2019) Que savons-nous de la rétinopathie diabétique au Centre Hospitalier Universitaire Sour&amp;#244; Sanou de Bobo-Dioulasso (CHUSS)? Journal Fran&amp;#231;ais d’Ophtalmologie, 42, 361-367. https://doi.org/10.1016/j.jfo.2018.11.002</mixed-citation></ref><ref id="scirp.122634-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Rajaona, R.A., Volamarina, R.F., Andriamahenina, A.M., Raobela, L., Bernardin, P. and Andriantsoa, V. (2016) Aspect épidémiologique de la rétinopathie diabétique, étude bicentrique à Antananarivo (Madagascar), à propos de 158 cas. Journal Fran&amp;#231;ais d’Ophtalmologie, 39, e137-e138. https://doi.org/10.1016/j.jfo.2015.11.012</mixed-citation></ref><ref id="scirp.122634-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Magulike, N.O., Chuka-Okosa, C.M. and Oli, J.M. (2003) Diabetic Eye Disease in Enugu South-Eastern Nigeria—A Preliminary Report. Nigerian Journal of Ophthalmology, 11, 30-33. https://doi.org/10.4314/njo.v11i1.11895</mixed-citation></ref><ref id="scirp.122634-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Omolase, C.O., Adekanle, O., Owoeye, J.F.A. and Omolase, B.O. (2010) Diabetic Retinopathy in a Nigerian Community. Singapore Medical Journal, 51, 56-59.</mixed-citation></ref><ref id="scirp.122634-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Assavedo, A., Codjo, L., Alassani, A., Adoukonou, T., Codjo, P., Monteiro, S., et al. (2016) Risk Factors of Retinopathy among Diabetic’s Patients in Benin in 2014. Journal of Ophthalmology &amp; Clinical Research, 3, 1-5. https://doi.org/10.24966/OCR-8887/100025</mixed-citation></ref><ref id="scirp.122634-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Maammar, F., Snoussaoui, Y., Benhedji, F., Benbekhti, S., Seddiki, A., Bensalah, O., et al. (2014) P247 Facteurs de risque de la rétinopathie diabétique à Tlemcen. Diabetes &amp; Metabolism Journal, 40, A86. https://doi.org/10.1016/S1262-3636(14)72538-8</mixed-citation></ref><ref id="scirp.122634-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Djagadou, K.A., Balaka, A., Tchamdja, T., Nemi, K.D., Dadjo, S., Tambourou, E., et al. (2017) Diabete chez le sujet agé au Togo. Journal de la Recherche Scientifique de l’Université de Lomé, 19, 363-367.</mixed-citation></ref><ref id="scirp.122634-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Cui, Y., Zhang, M., Zhang, L., Zhang, L., Kuang, J., Zhang, G., et al. (2019) Prevalence and Risk Factors for Diabetic Retinopathy in a Cross-Sectional Population-Based Study from Rural Southern China: Dongguan Eye Study. BMJ Open, 9, e023586. https://doi.org/10.1136/bmjopen-2018-023586</mixed-citation></ref><ref id="scirp.122634-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Ben Ahmed, I., Houes Rehaiem, K., Tounsi, H., Amri, R., Azzabi, S., Ben Ammou, B., et al. (2016) étude épidémiologique descriptive des diabétiques de type 1 dans la région de Nabeul en Tunisie. Annales d’Endocrinologie, 77, 498-528. https://doi.org/10.1016/j.ando.2016.07.746</mixed-citation></ref><ref id="scirp.122634-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Pirie, F.J., Maharaj, S., Esterhuizen, T.M., Paruk, I.M. and Motala, A.A. (2014) Retinopathy in Subjects with Type 2 Diabetes at a Tertiary Diabetes Clinic in Durban, South Africa: Clinical, Biochemical and Genetic Factors. Journal of Clinical &amp; Translational Endocrinology, 1, e9-e12. https://doi.org/10.1016/j.jcte.2013.12.002</mixed-citation></ref><ref id="scirp.122634-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Giraneza, R. and Semanyenzi, S. (2012) Risk Factors and Prevalence of Diabetic Retinopathy in Adult Diabetic Patients Consulting at Kigali University Teaching Hospital. Rwanda Medical Journal, 70, 14-19.</mixed-citation></ref><ref id="scirp.122634-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">He, B.-B., Wei, L., Gu, Y.-J., Han, J.-F., Li, M., Liu, Y.-X., et al. (2012) Factors Associated with Diabetic Retinopathy in Chinese Patients with Type 2 Diabetes Mellitus. International Journal of Endocrinology, 2012, Article ID: 157940. https://doi.org/10.1155/2012/157940</mixed-citation></ref><ref id="scirp.122634-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Rasoulinejad, A., Hajian-Tilaki, K. and Mehdipour, E. (2015) Associated Factors of Diabetic Retinopathy in Patients That Referred to Teaching Hospitals in Babol. Caspian Journal of Internal Medicine, 6, 224-228.</mixed-citation></ref><ref id="scirp.122634-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Djrolo, F., Para&amp;#239;so, N.M., Diarra, O. and Makoutode, M. (2014) Diabetes Complications and Associated Factors in Type 2 Diabetic Patients in Cotonou. Journal of Diabetes Mellitus, 4, 311-315. https://doi.org/10.4236/jdm.2014.44043</mixed-citation></ref><ref id="scirp.122634-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">López, M., Cos, F.X., álvarez-Guisasola, F. and Fuster, E. (2017) Prevalence of Diabetic Retinopathy and Its Relationship with Glomerular Filtration Rate and Other Risk Factors in Patients with Type 2 Diabetes Mellitus in Spain. Journal of Clinical &amp; Translational Endocrinology, 9, 61-65. https://doi.org/10.1016/j.jcte.2017.07.004</mixed-citation></ref><ref id="scirp.122634-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Berkia, I., Gharbi, M.E.H., Chra&amp;#239;bi, A. and Iraqi, H. (2014) La microalbuminurie: S’agit-il d’un facteur de risque épidémiologique de la rétinopathie diabétique (à propos de 79 cas). Annales d’Endocrinologie, 75, 374. https://doi.org/10.1016/j.ando.2014.07.347</mixed-citation></ref><ref id="scirp.122634-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Chaine, G. and Massin, P. (2000) Rétinopathie diabétique. Dans: Ophtalmologie. Inter Med, Paris, 207-216.</mixed-citation></ref><ref id="scirp.122634-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Andaloussi, Z., Rezzoug, B., Loudghiri, M., Jennane, N., Hajji, Z., Boulanouar, A., et al. (2015) Prévalence de la rétinopathie diabétique et facteurs de risque associés dans la région de Rabat. Journal de la Société Marocaine d’Ophtalmologie, No. 24, 10-14.</mixed-citation></ref><ref id="scirp.122634-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Mallika, P., Lee, P., Cheah, W., Wong, J., Syed Alwi, S., Nor Hayati, H., et al. (2011) Risk Factors for Diabetic Retinopathy in Diabetics Screened Using Fundus Photography at a Primary Health Care Setting in East Malaysia. Malaysian Family Physician, 6, 60-65.</mixed-citation></ref><ref id="scirp.122634-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Ahmed, R.A., Khalil, S.N. and Al-Qahtani, M.A.A. (2016) Diabetic Retinopathy and the Associated Risk Factors in Diabetes Type 2 Patients in Abha, Saudi Arabia. Journal of Family and Community Medicine, 23, 18-24. https://doi.org/10.4103/2230-8229.172225</mixed-citation></ref><ref id="scirp.122634-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">De Médeiros-Quénum, M.D., Ndiaye, P.A., Cissé, A., Wane, A., Diop, S.N., Ndoye-Roth, P.A., et al. (2003) Aspects épidémiologiques et angiofluorographiques de la rétinopathie diabétique au Sénégal. Journal Fran&amp;#231;ais d’Ophtalmologie, 26, 160-163.</mixed-citation></ref></ref-list></back></article>